PIXIEGENE A/S: Financial statements 2018
CVR: 29848807
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
PIXIEGENE A/S (CVR 29848807) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 114,608 and a net result of DKK -1,508,232 compared with DKK -1,753,179 the year before. That is a decrease of 80.3% compared with the year before. The profit margin was -1,316%. Equity in the 2018 report amounted to DKK -1,544,912.
- Revenue
- DKK 114,608
- Gross Profit
- DKK -1,332,342
- Profit/Loss
- DKK -1,508,232
- Equity
- DKK -1,544,912
- Total Assets
- DKK 530,694
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 115 t. | -1.3 mio. | -1.5 mio. | -1.5 mio. | - |
| 2017 | 581 t. | -1.5 mio. | -1.8 mio. | -612 t. | - |
| 2016 | 123 t. | -1.5 mio. | -1.8 mio. | -2 t. | - |
| 2015 | 670 t. | -533 t. | -852 t. | 511 t. | - |
| 2014 | 264 t. | -340 t. | -748 t. | -287 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
PIXIEGENE A/S has published its annual report for 2017. Revenue came to DKK 580,895, and the net result was DKK -1,753,179.
As of March 5, 2018, Jack Taaning Johansen has joined the board of directors of PIXIEGENE A/S.
As of March 5, 2018, Thomas Muurmann Henriksen has left the board of directors of PIXIEGENE A/S.
As of March 5, 2018, Sarah Mai Scheel Edelmann is registered as vice chairman of PIXIEGENE A/S.
As of March 4, 2018, Sarah Mai Scheel Edelmann has left the board of directors of PIXIEGENE A/S.
As of March 4, 2018, Jack Taaning Johansen has stepped down as vice chairman of PIXIEGENE A/S.
About PIXIEGENE A/S
PIXIEGENE A/S was a Danish company of the type Aktieselskab based in København V, founded in 2006. The company has been dissolved on 24 February 2023. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 0 employees (2018). In 2021, the company reported revenue of DKK 2,000,000 and a net result of DKK 1,872,849 compared with DKK -83,007 the year before. Equity in the 2021 report amounted to DKK 113,359.